Commercially launched in the U.S. in November 2025, TONMYA (cyclobenzaprine HCl sublingual tablets) for long-term daily dosing at bedtime is the ...
Seaport Therapeutics ("Seaport" or the "Company"), a clinical-stage therapeutics company advancing novel neuropsychiatric medicines with a proven strategy and team, today announced the award of an up ...
Orforglipron, a novel oral nonpeptide GLP-1 receptor agonist (RA), led to a greater reduction in A1c and more significant weight loss compared to oral semaglutide in patients with type 2 diabetes (T2D ...
ARPA-H award supports the development of an oral prodrug using Seaport’s proprietary Glyph™ platform to address dysfunctional gut lymphatics and local inflammation linked to metabolic disease and ...
Seaport Therapeutics and MIPS awarded up to $15 mn from ARPA-H to advance Seaport’s GlyphCele, the first oral therapeutic designed to restore gut lymphatic function: Boston Thur ...
An informational 2026 consumer report examining Purisaki Berberine Patches' transdermal delivery claims, ingredient research ...
An independent informational overview of MEDVi's compounded tirzepatide telehealth program, including regulatory ...
Dominik Bošnjak is a freelance writer from Croatia. He has been writing about games for as long as he can remember and began doing so professionally in 2010 because an opportunity presented itself ...
Dalton Cooper is the Managing Editor of GameRant. Dalton has been writing about video games professionally since 2011. Having written thousands of game reviews and articles over the course of his ...
SAN ANTONIO – More than 20 galleries and studios at the Blue Star Arts Complex are getting ready for “First Friday,” a monthly celebration of local art. Business owners are hopeful for continued ...
Snow tapered off across Reno-Tahoe overnight, but icy roads and cold temperatures are expected to make for a slick Friday morning commute. Interstate 80 reopened over Donner Pass after earlier ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results